Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity
Authors
Keywords
Melanoma brain metastases, Ipilimumab immunotherapy, Stereotactic radiosurgery, Clinical outcomes, Radiation toxicity
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-25
DOI
10.1007/s11060-018-2880-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects
- (2018) Kevin Diao et al. JOURNAL OF NEUROSURGERY
- Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
- (2017) Noelle L. Williams et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab
- (2017) Or Cohen-Inbar et al. JOURNAL OF NEUROSURGERY
- Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
- (2017) Yi An et al. RADIOTHERAPY AND ONCOLOGY
- Irradiation and immunotherapy: From concept to the clinic
- (2016) April K. S. Salama et al. CANCER
- Predictors of Radiation Necrosis in Long-term Survivors of Stereotactic Radiosurgery for Brain Metastases
- (2016) Z.A. Siddiqui et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
- (2016) Rovel J. Colaco et al. JOURNAL OF NEUROSURGERY
- Systemic Immunotherapy for the Treatment of Brain Metastases
- (2016) Justine V. Cohen et al. Frontiers in Oncology
- Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
- (2015) Ana P. Kiess et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Immune Checkpoint Blockade in Patients With Melanoma Metastatic to the Brain
- (2015) Anna Maria Di Giacomo et al. SEMINARS IN ONCOLOGY
- Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
- (2014) Karim Tazi et al. Cancer Medicine
- Antitumor immune responses induced by ionizing irradiation and further immune stimulation
- (2013) Benjamin Frey et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
- (2013) Emily F. Stamell et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
- (2013) Maya Mathew et al. MELANOMA RESEARCH
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- Ipilimumab and radiation therapy for melanoma brain metastases
- (2013) Ann W. Silk et al. Cancer Medicine
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies
- (2012) Stephanie Du Four et al. EUROPEAN JOURNAL OF CANCER
- Melanoma brain metastasis: overview of current management and emerging targeted therapies
- (2012) Ekokobe Fonkem et al. Expert Review of Neurotherapeutics
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Determinants of survival in patients with brain metastases from cutaneous melanoma
- (2010) M Staudt et al. BRITISH JOURNAL OF CANCER
- Trafficking of immune cells in the central nervous system
- (2010) Emma H. Wilson et al. JOURNAL OF CLINICAL INVESTIGATION
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
- (2009) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started